Detailed Information on Publication Record
2015
Kdy indikovat empirickou antibiotickou léčbu u akutní komunitní gastroenterokolitidy suspektní bakteriální etiologie?
POLÁK, Pavel, Zbyněk BORTLÍČEK, M. VRBA, Jana JURÁNKOVÁ, M. FREIBERGEROVÁ et. al.Basic information
Original name
Kdy indikovat empirickou antibiotickou léčbu u akutní komunitní gastroenterokolitidy suspektní bakteriální etiologie?
Name (in English)
When should empirical antibiotic therapy be indicated in acute community-onset diarrhea of suspected bacterial etiology
Authors
POLÁK, Pavel (203 Czech Republic, guarantor, belonging to the institution), Zbyněk BORTLÍČEK (203 Czech Republic, belonging to the institution), M. VRBA (203 Czech Republic), Jana JURÁNKOVÁ (203 Czech Republic, belonging to the institution), M. FREIBERGEROVÁ (203 Czech Republic) and Petr HUSA (203 Czech Republic, belonging to the institution)
Edition
Klinická mikrobiologie a infekční lékařství, Praha, Trios, 2015, 1211-264X
Other information
Language
Czech
Type of outcome
Článek v odborném periodiku
Field of Study
30300 3.3 Health sciences
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/15:00083617
Organization unit
Faculty of Medicine
Keywords (in Czech)
Komunitní průjem; salmonelóza; kampylobakterióza; antibiotická léčba; rezistence k antibiotikům
Keywords in English
Antibiotic resistance; Antibiotic treatment; Campylobacteriosis; Community-onset diarrhea; Salmonellosis
Tags
Tags
International impact, Reviewed
Změněno: 25/8/2015 15:10, Jana Dvořáková
V originále
Cíl práce: Popsat základní charakteristiky dospělých pacientů s akutní komunitní salmonelózou či kampylobakteriózou. Dle výsledků analýzy aktualizovat diagnosticko-terapeutické algoritmy. Materiál a metody: Sběr dat probíhal retrospektivně v období od 1. 1. 2011 do 31. 12. 2013. Dle charakteristik při přijetí do nemocnice byli pacienti zařazeni do dvou skupin: skupina riziková se systémovými příznaky splňující alespoň dvě kritéria syndromu systémové zánětlivé odpovědi a pacienti s elevací prokalcitoninu v séru (nad 0,5 ng/ml). Onemocnění u ostatních pacientů bylo hodnoceno jako prostá intestinální forma. Pacienti s komunitní postantibiotickou kolitidou byli ze studie vyřazeni. Data byla statisticky zpracována.
In English
Background: The aims of this study were to describe the basic parameters of adult patients with acute community-onset salmonellosis or campylobacteriosis responsible for more than 90 % of all cases of community-onset diarrhea in the Czech Republic, and, according to the results of this analysis, to update the diagnostic and therapeutic algorithms. Materials and methods: The data were collected retrospectively between January 1, 2011 and December 31, 2013. Patients with systemic signs of infection having at least 2 signs of systemic inflammatory response syndrome (SIRS) or with elevated serum procalcitonin levels (more than 0.5 ng/ml) were classified as being at risk for the invasive form of the disease. The remaining patients were classified as having the simple intestinal form of the disease. Patients with community-onset post-antibiotic diarrhea were excluded. The data were statistically processed. Results: The following clinical factors were statistically significantly correlated with the high-risk form of the disease: duration of illness of less than 3 days before admission and any of the following (some of them are part of the SIRS classification), even after being adjusted for age: body temperature above 38 °C, peripheral blood white cell count (WBC) above 12 × 109/L, neutrophil count above 9 × 109/L and CRP level above 150 mg/L. The risk form of the disease occurred in 60 cases (18.7 %). The mean WBC was 9.4 × 109/1 (median, 8.4; range, 1.7-89.0). The WBC within the normal range was seen in 194 cases (60.4 %). The mean CRP level was 92.9 mg/1 (median, 77.0; range, 1.0-342.0). An elevated procalcitonin level was seen in 21 patients; the marker was not routinely measured. Positive blood culture results were obtained in 2 persons with salmonellosis; the examination was not routinely performed. There were 34 patients (10.6 %) with documented immune system dysfunction; the risk form of salmonellosis or campylobacteriosis was seen in only 11 of them (3.4 %). A total of 306 patients (95.3 %) were treated with antibiotics; the mean duration of antibiotic therapy was 8.7 days (median, 7; range, 2-31). Conclusions: Antibiotic treatment in salmonellosis/campylobacteriosis should not be indicated only due to elevated CRP levels but rather after comprehensive evaluation of the duration of symptoms, individual risk factors and dynamic changes in markers of inflammation. Blood culture tests should be carried out more frequently.